Primary hyperparathyroidism and negative Tc99 sestamibi imaging: To operate or not?

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2272-2278

  Dy, Benzon M ^a   Richards, Melanie L ^a   Vazquez, Bianca J ^a   Thompson, Geoffrey B ^a   Farley, David R ^a   Grant, Clive S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CREATININE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PHOSPHORUS;

ADOLESCENT; ADULT; AGED; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHILD; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CONVALESCENCE; CREATININE CLEARANCE; FEMALE; FEMUR NECK; FROZEN SECTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OSTEOLYSIS; PREDICTIVE VALUE; PREOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; REVIEW; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURVIVAL RATE; TECHNETIUM TC 99M SESTAMIBI; YOUNG ADULT;

EID: 84865126783     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2325-3     Document Type: Review

References (22)

1. Irvin GL III, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704-11. (Pubitemid 38525642)
2. Van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg. 1991;15:688-92.
3. Van Heerden JA, Bearhrs OH, Wollner LB. The pathology and surgical management of primary hyperparathyroidism. Surg Clin North Am. 1977;57:557-63. (Pubitemid 8110359)
4. Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-70.
5. 99Tcm-sestamibi-a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791-4. (Pubitemid 20046362)
6. Civelek AC, Ozalp E, Donovan P, et al. Prospective evaluation of delayed technetium-99 m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131:149-57. (Pubitemid 34169540)
7. Sharma J, Mazzaglia P, Milas M, et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99 m sestamibi modality? Surgery. 2006;140:856-63.
8. Norton KS, Johnson LW, Griffen FD, et al. The sestamibi scan as a preoperative screen tool. Am Surg. 2002;68:812-5. (Pubitemid 44971208)
9. Grant C, Thompson G, Farley D, Van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy. Arch Surg. 2005; 140:472-8.
10. Arici C, Cheah WK, Ituarte PH, et al. Can localization studies be used to direct focused parathyroid operations? Surgery. 2001; 129:720-9. (Pubitemid 32493675)
11. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171-7. (Pubitemid 43023239)
12. Proceedings of the NIDDK Workshop program. Asymptomatic primary hyperparathyroidism: a perspective for the 21st century. Bethesda, April 8-9, 2002. J Bone Miner Res. 2002;17(Suppl): N1-162.
13. AACE/AAES Task Force on Primary Hyperparathyroidism. American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroid-ism. Endocr Pract. 2005;11:49-54.
14. Bilezikian JP, Potts JT, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-61. (Pubitemid 36034328)
15. Lew JI, Rivera M, Irvin GL 3rd, Solorzano CC. Operative failure in the era of focused parathyroidectomy. Arch Surg. 2010;145: 628-33.
16. Siperstein A, Berber E, Barbosa GF, et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg. 2008;248:420-8.
17. Solorzano CC, Lee TM, Ramirez MC, et al. Surgeon performed ultrasound improves localization of abnormal parathyroid glands. Am Surg. 2005;71:557-62.
18. Kebapci M, Entok E, Kebapci N, et al. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase techne-tium 99 m sestamibi scintigraphy. J Endocrinol Invest. 2004;27: 24-30. (Pubitemid 38324715)
19. Bergenfelz AO, Wallin G, Jansson S, et al. Results of surgery for sporadic primary hyperparathyroidism in patients with preoper-atively negative sestamibi scintigraphy and ultrasound. Langenbecks Arch Surg. 2011;396:83-90.
20. Rodgers SE, Hunter GJ, Hamberg LM, et al. Improved preoper-ative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006;140:932-4.
21. Starker LF, Mahajan A, Björklund P, Sze G, Udelsman R, Car-ling T. 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol. 2011;18:1723-8.
22. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249-55. (Pubitemid 29489739)